Are there generic versions of crizotinib?
The original drug Crizotinib (Crizotinib) is currently on the market for sale in many overseas countries. It is a drug for the treatment of certain mutated non-small cell lung cancer (NSCLC), anaplastic large cell lymphoma (ALCL), and inflammatory myofibroblastic tumor (IMT). It is understood that generic drugs of crizotinib are currently produced and sold. Its pharmaceutical ingredients are basically the same as those of the original drug. There may be slight differences in production specifications and prices. Common manufacturers of generic drugs include Yaopin International of Bangladesh, Lucius Pharmaceutical Factory of Laos, etc.

Crizotinib belongs to a class of drugs called kinase inhibitors, which work by blocking the action of a naturally occurring substance that may be necessary to help cancer cells multiply. Crizotinib is used to treat certain types of non-small cell lung cancer that have spread to nearby tissues or other parts of the body. It is also used to treat certain types of anaplastic large cell lymphoma in adults and children 1 year of age and older that have come back or have not responded to other treatments. Treatment for a certain type of inflammatory myofibroblastic tumor (a cancer that develops in mucosal tissue (usually in the abdominal area involving the lungs, bladder, stomach, uterus, liver, or intestines)) that cannot be treated with surgery or has not improved or has come back after previous treatment in adults and children 1 year and older.
Specifications of the original drug Crizotinib sold domestically and abroadThe price of 250mg*60 capsules per box may be more than 10,000 yuan, which is relatively expensive. However, the domestically marketed drugs have been included in the scope of Class B medical insurance, and the price for patients who meet the indications will be reduced. The generic crizotinib currently on the market for sale overseas may cost around RMB 2,000 per box of 250mg*60 capsules (the price may fluctuate due to exchange rates).
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)